| Literature DB >> 22064971 |
Hua Wang1, Zhi-Hao Wang, Jing Kong, Meng-Yun Yang, Gui-Hua Jiang, Xu-Ping Wang, Ming Zhong, Yun Zhang, Jing-Ti Deng, Wei Zhang.
Abstract
The fundamental mechanisms that underlie platelet activation in atherothrombosis are still obscure. Oxidative stress is involved in central features of atherosclerosis. Platelet-derived microvesicles (PMVs) could be important mediators between oxidative stress and platelet activation. CD36 could be a receptor of PMVs, thus generating a PMV-CD36 complex. We aimed to investigate the detailed pathway by which oxidative damage contributes to platelet activation by the PMV-CD36 complex. We found that oxidized low-density lipoprotein stimulated the generation of PMVs. PMVs enhanced normal platelet activation, as assessed by the expression of integrin α(IIb)β₃, secretion of soluble P-selectin and platelet aggregation, but CD36-deficient platelets were not activated by PMVs. The function of the PMV-CD36 complex was mediated by the MKK4/JNK2 signaling axis. Meanwhile, PMVs increased the level of 8-iso-prostaglandin-F2α, a marker of oxidative stress, in a CD36- and phosphatidylserine-dependent manner. We concluded that PMVs are important mediators between oxidative stress and platelet activation. PMVs and CD36 may be effective targets for preventing platelet activation in cardiovascular diseases.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22064971 PMCID: PMC3320142 DOI: 10.2119/molmed.2011.00295
Source DB: PubMed Journal: Mol Med ISSN: 1076-1551 Impact factor: 6.354